Physician profile
Robert A Pickett
NPI 1932128782
$95,402.09
in general payments reported to CMS, 2019-2025
16 companies · $22K in 2025
The $22K reported for 2025 was more than what 90% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,156 · 2020: $4,014 · 2021: $10K · 2022: $27K · 2023: $9,560 · 2024: $16K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Consulting Fee: $15K · Food and Beverage: $8,933 · Travel and Lodging: $4,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,500.00 |
| Consulting Fee | $14,937.50 |
| Food and Beverage | $8,932.78 |
| Travel and Lodging | $4,127.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $81,597.16 | 2019-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Medtronic Vascular, INC. | $7,394.27 | 2019-2020 | |
| Medtronic, INC. | $5,003.49 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Abbott Laboratories | $810.44 | 2020-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet, Flexability |
| Preventice Services, LLC | $223.17 | 2021 | |
| Abiomed | $130.12 | 2022 | |
| Irhythm Technologies, INC. | $87.62 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $35.18 | 2024-2025 | |
| Daiichi Sankyo INC. | $25.10 | 2025 | Injectafer |
| Janssen Pharmaceuticals, INC | $20.43 | 2024 | Xarelto |
| Novo Nordisk INC | $18.55 | 2023 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.95 | 2021-2022 | |
| Cvrx, INC. | $14.26 | 2021 | |
| Sanofi-Aventis U.S. LLC | $14.00 | 2023 | |
| Novartis Pharmaceuticals Corporation | $13.35 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Pickett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.